Oncology 101

Oncology Drug Development: What Is Changing?

Mary Ann Yancey

drug
CJON 2008, 12(5), 713-715. DOI: 10.1188/08.CJON.713-715
Members Only
Not a current ONS member or journal subscriber?

Become a Member

Explore the benefits of membership.
Join ONS or Renew Membership

Purchase This Article

Receive a PDF to download and print.